MTOR signaling pathway and mTOR inhibitors in cancer: Progress and challenges

48Citations
Citations of this article
219Readers
Mendeley users who have this article in their library.

This artice is free to access.

Abstract

Mammalian target of rapamycin (mTOR) regulates cell proliferation, autophagy, and apoptosis by participating in multiple signaling pathways in the body. Studies have shown that the mTOR signaling pathway is also associated with cancer, arthritis, insulin resistance, osteoporosis, and other diseases. The mTOR signaling pathway, which is often activated in tumors, not only regulates gene transcription and protein synthesis to regulate cell proliferation and immune cell differentiation but also plays an important role in tumor metabolism. Therefore, the mTOR signaling pathway is a hot target in anti-tumor therapy research. In recent years, a variety of newly discovered mTOR inhibitors have entered clinical studies, and a variety of drugs have been proven to have high activity in combination with mTOR inhibitors. The purpose of this review is to introduce the role of mTOR signaling pathway on apoptosis, autophagy, growth, and metabolism of tumor cells, and to introduce the research progress of mTOR inhibitors in the tumor field.

Cite

CITATION STYLE

APA

Zou, Z., Tao, T., Li, H., & Zhu, X. (2020, March 10). MTOR signaling pathway and mTOR inhibitors in cancer: Progress and challenges. Cell and Bioscience. BioMed Central Ltd. https://doi.org/10.1186/s13578-020-00396-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free